We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sepracor Claims Patent Priority Over Wyeth's Pristiq

Law360 (April 17, 2009, 12:00 AM EDT) -- Pharmaceutical rivals Sepracor Inc. and Wyeth Inc. are battling in the U.S. Patent and Trademark Office for inventorship rights to Pristiq, a Wyeth drug used to treat depression in adults....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.